Report Summary

The global facial injectable market was estimated at USD 7,126.65 Million in 2017 and is anticipated to gain significant traction over coming years. Facial injectable, also called dermal fillers, are generally the products that aid in facial transformation. In general, the facial injectable products are widely used to extravagance the early signs of age and wrinkles thereby increasing the visual appearance and the beauty. In addition, changing insight of beauty is demanding the increased use of dermal fillers and other facial injectable all over the world. Some of the vital uses of facial injectable include raising scar depressions, bio-engineering of the facial skin and facial rejuvenation and many other. Although the surgical transformation has been the vital choice of treatment, specialists at present are favoring facial dermal fillers as a corresponding to surgical processes such as the facelift. Moreover, collagen injections are being used as a dermal filler for the facial defectiveness. However, the launch of synthetic calcium hydroxyl apatite fillers in the market has changed the trends eventually. Because of these fillers, the injectable products show more stability as compared to natural collagen fillers and as an outcome providing deep dermal effects.

The global facial injectable market is driven by increasing demand to look young and beautiful. The target age group for the facile injectable products are primarily women age between 35 to 60 years. Nonetheless, both women and men are using facial injectable products to achieve and maintain the young look. Moreover, growing demand for non-surgical procedures for facial transformation and modification is expected to be a factor boosting the growth of the facial injectable market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2016, non-surgical procedures including injectable accounted for approximately 8 million global surgeries. In addition, the rise in a pool of elderly population and the launch of better facial injectable such as synthetic calcium hydroxyl apatite fillers further propel the market growth. However, stringent regulatory concerns regarding injectable products and side effects associated with such products including rashes are anticipated to hinder the market growth.

Segment Analysis

The global Facial Injectable Market is segmented on the basis of products, end users, and geography. On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017. Moreover, this segment is anticipated to show lucrative growth during the forecast period. Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression. On the basis of the end user, the global Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market.

Regional Analysis

In terms of geography, North America is estimated to dominate the global Facial Injectable Market. The dominance is majorly attributed to the rise in the spending on cosmetic procedures. The existence of a large elderly population in the U.S. and Canada is expected to fuel the demand for facial injectable market during the forecast period. Moreover, growing consciousness about forward-looking beauty treatments and rising prominence about physical appearance is also anticipated to bolster the market growth. However, Asia Pacific is anticipated to generate the lucrative growth during the forecast period. Rising beauty concern among the mid-age population and geriatric population are the factors enhancing the facial injectable market in the Asia Pacific.

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global Facial Injectable Market includes Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc., Suneva Medical, Inc. among others.